Design Therapeutics (DSGN.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov6

Design Therapeutics released FY2025 9 Months earnings on November 5 (EST), actual revenue USD 0, actual EPS USD -0.9461

04:00

Design Therapeutics released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3 (forecast USD -0.34)

04:00

Aug8

Design Therapeutics released FY2025 Semi-Annual Earnings on August 7 (EST) with actual revenue of USD 0 and EPS of USD -0.6477

03:00

Design Therapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3356 (forecast USD -0.32)

03:00

Jun12

Design Therapeutics Annual Shareholders Meeting Elects New Directors

20:20

Jun4

Design Therapeutics Begins DT-216P2 Clinical Trials for Friedreich's Ataxia Patients

11:32

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -17 M, EPS -0.2984

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -19.08 M, EPS -0.3356

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -17.72 M, EPS -0.3121

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More